Department of Psychiatry, Beaumont Hospital and The Royal College of Surgeons in Ireland
Laboratory of Membrane Biochemistry and Biophysics, National Institute on Alcohol Abuse and Alcoholism, Rockville, Maryland, USA
Institute of Psychiatry, University of Illinois at Chicago, Illinois, USA
Department of Psychiatry, Beaumont Hospital and the Royal College of Surgeons in Ireland, Ireland.
Correspondence: Dr Malcolm R. Garland, St Itas Hospital, Portrane, County Dublin, Ireland. Email: mgarland{at}ireland.com
Declaration of interest Pronova (now Epax) AS, Lysaker, Norway, provided the active preparation and placebo but were not otherwise involved in the study. Funding detailed in Acknowledgements.
See pp.
112117, this
issue.
Background Trials have demonstrated benefits of long-chain omega-3 essential fatty acid (n-3 EFA) supplementation in a variety of psychiatric disorders.
Aims To assess the efficacy of n-3 EFAs in improving psychological well-being in patients with recurrent self-harm.
Method Patients (n=49) presenting after an act of repeated self-harm were randomised to receive 1.2 g eicosapentaenoic acid plus 0.9 g decosahexaenoic acid (n=22) or placebo (n=27) for 12 weeks in addition to standard psychiatric care. Six psychological domains were measured at baseline and end point.
Results At 12 weeks, the n-3 EFA group had significantly greater improvements in scores for depression, suicidality and daily stresses. Scores for impulsivity, aggression and hostility did not differ.
Conclusions Supplementation achieved substantial reductions in surrogate markers of suicidal behaviour and improvements in well-being. Larger studies are warranted to determine if insufficient dietary intake of n-3 EFAs is a reversible risk factor for self-harm.
Related articles in BJP:
This article has been cited by other articles:
![]() |
P. Tyrer Sentinels on the road to disaster. The British Journal of Psychiatry, October 1, 2009; 195(4): 378 - 378. [Full Text] [PDF] |
||||
![]() |
N. Vaisman, N. Kaysar, Y. Zaruk-Adasha, D. Pelled, G. Brichon, G. Zwingelstein, and J. Bodennec Correlation between changes in blood fatty acid composition and visual sustained attention performance in children with inattention: effect of dietary n-3 fatty acids containing phospholipids Am. J. Clinical Nutrition, May 1, 2008; 87(5): 1170 - 1180. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Basu and P. K. Barnwal Omega-3 fatty acid for recurrent self-harm: unanswered questions The British Journal of Psychiatry, September 1, 2007; 191(3): 264 - 264. [Full Text] [PDF] |
||||
![]() |
Recurrent Self-Harm: Are Omega-3 Supplements Part of the Answer? Journal Watch Psychiatry, March 12, 2007; 2007(312): 2 - 2. [Full Text] |
||||
![]() |
M. R. GARLAND, B. HALLAHAN, M. McNAMARA, P. A. CARNEY, H. GRIMES, J. R. HIBBELN, A. HARKIN, and R. M. CONROY Lipids and essential fatty acids in patients presenting with self-harm The British Journal of Psychiatry, February 1, 2007; 190(2): 112 - 117. [Abstract] [Full Text] [PDF] |
||||
Read all eLetters